-Lactamase inhibition by avibactam in Mycobacterium abscessus

In VivoAssessment of Drug Efficacy against Mycobacterium abscessus Using the Embryonic Zebrafish Test System

(2014) Audrey Bernut et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Microbiological interaction studies between ceftazidime-avibactam and pulmonary surfactant and between ceftazidime-avibactam and antibacterial agents of other classes

(2014) John Dallow et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation

(2014) A. Bernut et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Single- and Multiple-Dose Study To Determine the Safety, Tolerability, and Pharmacokinetics of Ceftaroline Fosamil in Combination with Avibactam in Healthy Subjects

(2013) Todd A. Riccobene et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cutaneous Inoculation of Nontuberculous Mycobacteria During Professional Tattooing: A Case Series and Epidemiologic Study

(2013) Ryan R. Falsey et al.   CLINICAL INFECTIOUS DISEASES

In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex

(2013) M. Lavollay et al.   CLINICAL MICROBIOLOGY AND INFECTION

Characterization of broad-spectrum Mycobacterium abscessus class A  -lactamase

(2013) D. Soroka et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

(2013) Christopher Lucasti et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases

(2013) David E. Ehmann et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Kinetic Features of L,D-Transpeptidase Inactivation Critical for β-Lactam Antibacterial Activity

(2013) Sébastien Triboulet et al.   PLoS One

Macrolide Treatment forMycobacterium abscessusandMycobacterium massilienseInfection and Inducible Resistance

(2012) Go-Eun Choi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Meropenem-Clavulanic Acid Shows Activity against Mycobacterium tuberculosis In Vivo

(2012) Kathleen England et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

NXL104 Irreversibly Inhibits the β-Lactamase from Mycobacterium tuberculosis

(2012) Hua Xu et al.   BIOCHEMISTRY

Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study

(2012) José A. Vazquez et al.   CURRENT MEDICAL RESEARCH AND OPINION

Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis [Case study]

(2012) M. C. Payen et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Avibactam is a covalent, reversible, non- -lactam  -lactamase inhibitor

(2012) D. E. Ehmann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Meropenem/Clavulanate and Linezolid Treatment for Extensively Drug-resistant Tuberculosis

(2011) Nicolas Dauby et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants

(2010) Anne-Laure Roux et al.   CELLULAR MICROBIOLOGY

The Peptidoglycan of Mycobacterium abscessus Is Predominantly Cross-Linked by L,D-Transpeptidases

(2010) M. Lavollay et al.   JOURNAL OF BACTERIOLOGY

Mycobacterium abscessus: a new player in the mycobacterial field

(2010) Halima Medjahed et al.   TRENDS IN MICROBIOLOGY

A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae

(2009) K. A. Nash et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus

(2009) Fabienne Ripoll et al.   PLoS One

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

(2009) J.-E. Hugonnet et al.   SCIENCE

Construction of Mycobacterium abscessus Defined Glycopeptidolipid Mutants: Comparison of Genetic Tools

(2008) H. Medjahed et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

The Peptidoglycan of Stationary-Phase Mycobacterium tuberculosis Predominantly Contains Cross-Links Generated by L,D-Transpeptidation

(2008) M. Lavollay et al.   JOURNAL OF BACTERIOLOGY